220 related articles for article (PubMed ID: 6339042)
1. Biochemical effects and therapeutic potential of tunicamycin in murine L1210 leukemia.
Morin MJ; Bernacki RJ
Cancer Res; 1983 Apr; 43(4):1669-74. PubMed ID: 6339042
[TBL] [Abstract][Full Text] [Related]
2. The biochemical and ultrastructural effects of tunicamycin and D-glucosamine in L1210 leukemic cells.
Morin MJ; Porter CW; McKernan P; Bernacki RJ
J Cell Physiol; 1983 Feb; 114(2):162-72. PubMed ID: 6822608
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W
Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
[TBL] [Abstract][Full Text] [Related]
4. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
Li ZR; Campbell J; Rustum YM
Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
[TBL] [Abstract][Full Text] [Related]
5. Cell surface alterations associated with exposure of leukemia L1210 cells to fluorouracil.
Kessel D
Cancer Res; 1980 Feb; 40(2):322-4. PubMed ID: 7356515
[TBL] [Abstract][Full Text] [Related]
6. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.
Barrueco JR; Jacobsen DM; Chang CH; Brockman RW; Sirotnak FM
Cancer Res; 1987 Feb; 47(3):700-6. PubMed ID: 3802076
[TBL] [Abstract][Full Text] [Related]
7. Tissue pharmacokinetics, inhibition of DNA synthesis and tumor cell kill after high-dose methotrexate in murine tumor models.
Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
Cancer Res; 1976 Dec; 36(12):4672-8. PubMed ID: 1000510
[TBL] [Abstract][Full Text] [Related]
8. Induction of immune resistance against L1210 lymphatic leukemia in mice after chemoradiotherapy of the leukemia and reconstitution with bone marrow purged from the leukemia with mafosfamide.
Skórski T; Kawalec M
Exp Hematol; 1988 Oct; 16(9):782-4. PubMed ID: 3049130
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin.
Cass CE; Au-Yeung TH
Cancer Res; 1976 Apr; 36(4):1486-91. PubMed ID: 944095
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of selenium on the growth of L1210 leukemic cells.
Milner JA; Hsu CY
Cancer Res; 1981 May; 41(5):1652-6. PubMed ID: 7214335
[TBL] [Abstract][Full Text] [Related]
11. Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents.
Chou TC; Schmid FA; Feinberg A; Philips FS; Han J
Cancer Res; 1983 Jul; 43(7):3074-9. PubMed ID: 6189591
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of novel octalactin A analogs in murine leukemia cells in vitro.
Perchellet JP; Perchellet EM; Newell SW; Freeman JA; Ladesich JB; Jeong Y; Sato N; Buszek K
Anticancer Res; 1998; 18(1A):97-106. PubMed ID: 9568062
[TBL] [Abstract][Full Text] [Related]
13. Biological characterization of a prolonged antileukemic effect of 5-azacytidine.
Presant CA; Valeriote F; Vietti TJ
Cancer Res; 1977 Feb; 37(2):376-81. PubMed ID: 64294
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of DNA synthesis and enhancement of the uptake and action of methotrexate by low-power-density microwave radiation in L1210 leukemia cells.
Chang BK; Huang AT; Joines WT
Cancer Res; 1980 Apr; 40(4):1002-5. PubMed ID: 7357530
[TBL] [Abstract][Full Text] [Related]
15. In vivo antitumor activity of the bitter melon (Momordica charantia).
Jilka C; Strifler B; Fortner GW; Hays EF; Takemoto DJ
Cancer Res; 1983 Nov; 43(11):5151-5. PubMed ID: 6616452
[TBL] [Abstract][Full Text] [Related]
16. Curative effect of DL-2-difluoromethylornithine on mice bearing mutant L1210 leukemia cells deficient in polyamine uptake.
Persson L; Holm I; Ask A; Heby O
Cancer Res; 1988 Sep; 48(17):4807-11. PubMed ID: 3136913
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in vivo and in vitro effects of continuous exposure of L1210 cells to 6-thioguanine.
Maybaum J; Morgans CW; Hink LA
Cancer Res; 1987 Jun; 47(12):3083-7. PubMed ID: 3581060
[TBL] [Abstract][Full Text] [Related]
18. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
Irimura T; Gonzalez R; Nicolson GL
Cancer Res; 1981 Sep; 41(9 Pt 1):3411-8. PubMed ID: 7260906
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of L-canavanine against L1210 murine leukemia.
Green MH; Brooks TL; Mendelsohn J; Howell SB
Cancer Res; 1980 Mar; 40(3):535-7. PubMed ID: 7471074
[TBL] [Abstract][Full Text] [Related]
20. Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice.
Zaharko DS; Ramonas LM
J Natl Cancer Inst; 1982 May; 68(5):875-80. PubMed ID: 6951095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]